Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 173 entries
Sorted by: Best Match Show Resources per page
Use of engaging review application exercises to enhance understanding of critical concepts prior to summative examinations

engineering education

Cusick JK.
GSID: MN8yue3sHH8J
JK Cusick, L Fitzpatrick, P Khansari - Pharmacy Education, 2019 - ortofonshop.com

Two distinct and engaging review application exercises were created in an immunology class for third-year pharmacy students that utilised the Team-Based Learning (TBL) …

Cite
Cusick, J. K., Fitzpatrick, L., & Khansari, P. (2019). Use of engaging review application exercises to enhance understanding of critical concepts prior to summative examinations. Pharmacy Education, 19, 232-241.
Cusick, John K., Leo Fitzpatrick, and Parto Khansari. "Use of engaging review application exercises to enhance understanding of critical concepts prior to summative examinations." Pharmacy Education 19 (2019): 232-241.
Copy Download .nbib Format: MLA
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake.

Ecancermedicalscience

DeCensi A, Thorat MA, Bonanni B, Smith SG, Cuzick J.
PMID: 26635899
Ecancermedicalscience. 2015 Nov 24;9:595. doi: 10.3332/ecancer.2015.595. eCollection 2015.

The global cancer burden continues to rise and the war on cancer can only be won if improvements in treatment go hand in hand with therapeutic cancer prevention. Despite the availability of several efficacious agents, utilisation of preventive therapy...

Cite
DeCensi A, Thorat MA, Bonanni B, et al. Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake. Ecancermedicalscience. 2015;9:595doi: 10.3332/ecancer.2015.595.
DeCensi, A., Thorat, M. A., Bonanni, B., Smith, S. G., & Cuzick, J. (2015). Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake. Ecancermedicalscience, 9595. https://doi.org/10.3332/ecancer.2015.595
DeCensi, Andrea, et al. "Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake." Ecancermedicalscience vol. 9 (2015): 595. doi: https://doi.org/10.3332/ecancer.2015.595
DeCensi A, Thorat MA, Bonanni B, Smith SG, Cuzick J. Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake. Ecancermedicalscience. 2015 Nov 24;9:595. doi: 10.3332/ecancer.2015.595. eCollection 2015. PMID: 26635899; PMCID: PMC4664508.
Copy Download .nbib Format: NLM
Geospatial cryptography: enabling researchers to access private, spatially referenced, human subjects data for cancer control and prevention.

Journal of geographical systems

Jacquez GM, Essex A, Curtis A, Kohler B, Sherman R, Emam KE, Shi C, Kaufmann A, Beale L, Cusick T, Goldberg D, Goovaerts P.
PMID: 29085255
J Geogr Syst. 2017 Jul;19(3):197-220. doi: 10.1007/s10109-017-0252-3. Epub 2017 May 11.

As the volume, accuracy and precision of digital geographic information have increased, concerns regarding individual privacy and confidentiality have come to the forefront. Not only do these challenge a basic tenet underlying the advancement of science by posing substantial...

Cite
Jacquez GM, Essex A, Curtis A, et al. Geospatial cryptography: enabling researchers to access private, spatially referenced, human subjects data for cancer control and prevention. J Geogr Syst. 2017;19(3):197-220doi: 10.1007/s10109-017-0252-3.
Jacquez, G. M., Essex, A., Curtis, A., Kohler, B., Sherman, R., Emam, K. E., Shi, C., Kaufmann, A., Beale, L., Cusick, T., Goldberg, D., & Goovaerts, P. (2017). Geospatial cryptography: enabling researchers to access private, spatially referenced, human subjects data for cancer control and prevention. Journal of geographical systems, 19(3), 197-220. https://doi.org/10.1007/s10109-017-0252-3
Jacquez, Geoffrey M, et al. "Geospatial cryptography: enabling researchers to access private, spatially referenced, human subjects data for cancer control and prevention." Journal of geographical systems vol. 19,3 (2017): 197-220. doi: https://doi.org/10.1007/s10109-017-0252-3
Jacquez GM, Essex A, Curtis A, Kohler B, Sherman R, Emam KE, Shi C, Kaufmann A, Beale L, Cusick T, Goldberg D, Goovaerts P. Geospatial cryptography: enabling researchers to access private, spatially referenced, human subjects data for cancer control and prevention. J Geogr Syst. 2017 Jul;19(3):197-220. doi: 10.1007/s10109-017-0252-3. Epub 2017 May 11. PMID: 29085255; PMCID: PMC5659297.
Copy Download .nbib Format: NLM
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Histopathology

Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM, Todd IP.
PMID: 12405932
Histopathology. 2002 Sep;41(3):59-81.

No abstract available.

Cite
Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 2002;41(3):59-81
Jass, J. R., Atkin, W. S., Cuzick, J., Bussey, H. J., Morson, B. C., Northover, J. M., & Todd, I. P. (2002). The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology, 41(3), 59-81.
Jass, J R, et al. "The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases." Histopathology vol. 41,3 (2002): 59-81.
Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM, Todd IP. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 2002 Sep;41(3):59-81. PMID: 12405932.
Copy Download .nbib Format: NLM
BURN PREVENTION FORUM.

The Journal of burn care & rehabilitation

Cusick JM.
PMID: 11773753
J Burn Care Rehabil. 2001 Jan-Feb;22(1):70-71. doi: 10.1097/00004630-200101000-00014.

No abstract available.

Cite
Cusick JM. BURN PREVENTION FORUM. J Burn Care Rehabil. 2001;22(1):70-71doi: 10.1097/00004630-200101000-00014.
Cusick, J. M. (2001). BURN PREVENTION FORUM. The Journal of burn care & rehabilitation, 22(1), 70-71. https://doi.org/10.1097/00004630-200101000-00014
Cusick, Janet M.. "BURN PREVENTION FORUM." The Journal of burn care & rehabilitation vol. 22,1 (2001): 70-71. doi: https://doi.org/10.1097/00004630-200101000-00014
Cusick JM. BURN PREVENTION FORUM. J Burn Care Rehabil. 2001 Jan-Feb;22(1):70-71. doi: 10.1097/00004630-200101000-00014. PMID: 11773753.
Copy Download .nbib Format: NLM
Cervical screening in the United Kingdom.

Hong Kong medical journal = Xianggang yi xue za zhi

Cuzick J, Sasieni P.
PMID: 11828067
Hong Kong Med J. 1999 Sep;5(3):269-271.

It has been more than 10 years since the cervical screening system in the United Kingdom was completely overhauled and a computerised call and recall system was introduced. The current programme is very healthy and dramatic improvements have been...

Cite
Cuzick J, Sasieni P. Cervical screening in the United Kingdom. Hong Kong Med J. 1999;5(3):269-271
Cuzick, J., & Sasieni, P. (1999). Cervical screening in the United Kingdom. Hong Kong medical journal = Xianggang yi xue za zhi, 5(3), 269-271.
Cuzick, J, and Sasieni, P. "Cervical screening in the United Kingdom." Hong Kong medical journal = Xianggang yi xue za zhi vol. 5,3 (1999): 269-271.
Cuzick J, Sasieni P. Cervical screening in the United Kingdom. Hong Kong Med J. 1999 Sep;5(3):269-271. PMID: 11828067.
Copy Download .nbib Format: NLM
A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285].

Current controlled trials in cardiovascular medicine

Pater C, Bhatnagar D, Berrou JP, Luszick J, Beckmann K.
PMID: 15461784
Curr Control Trials Cardiovasc Med. 2004 Oct 01;5(1):9. doi: 10.1186/1468-6708-5-9.

Hypertension and diabetes mellitus are closely interrelated and coexist in as many as two-thirds of patients with type 2 diabetes. The consequent risk of such an association is an accelerated development of atherosclerotic cardiovascular disease and nephropathy complications.In choosing...

Cite
Pater C, Bhatnagar D, Berrou JP, et al. A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Curr Control Trials Cardiovasc Med. 2004;5(1):9doi: 10.1186/1468-6708-5-9.
Pater, C., Bhatnagar, D., Berrou, J. P., Luszick, J., & Beckmann, K. (2004). A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Current controlled trials in cardiovascular medicine, 5(1), 9. https://doi.org/10.1186/1468-6708-5-9
Pater, Cornel, et al. "A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]." Current controlled trials in cardiovascular medicine vol. 5,1 (2004): 9. doi: https://doi.org/10.1186/1468-6708-5-9
Pater C, Bhatnagar D, Berrou JP, Luszick J, Beckmann K. A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Curr Control Trials Cardiovasc Med. 2004 Oct 01;5(1):9. doi: 10.1186/1468-6708-5-9. PMID: 15461784; PMCID: PMC524514.
Copy Download .nbib Format: NLM
Interaction of statisticians with DMCs.

Statistics in medicine

Cuzick J.
PMID: 15880514
Stat Med. 2005 May 30;24(10):1609. doi: 10.1002/sim.2027.

No abstract available.

Cite
Cuzick J. Interaction of statisticians with DMCs. Stat Med. 2005;24(10):1609doi: 10.1002/sim.2027.
Cuzick, J. (2005). Interaction of statisticians with DMCs. Statistics in medicine, 24(10), 1609. https://doi.org/10.1002/sim.2027
Cuzick, Jack. "Interaction of statisticians with DMCs." Statistics in medicine vol. 24,10 (2005): 1609. doi: https://doi.org/10.1002/sim.2027
Cuzick J. Interaction of statisticians with DMCs. Stat Med. 2005 May 30;24(10):1609. doi: 10.1002/sim.2027. PMID: 15880514.
Copy Download .nbib Format: NLM
Chemoprevention of breast cancer.

Women's health (London, England)

Cuzick J.
PMID: 19804005
Womens Health (Lond). 2006 Nov;2(6):853-61. doi: 10.2217/17455057.2.6.853.

Trials with tamoxifen have clearly shown that estrogen receptor-positive breast cancer risk can be reduced at a late stage in the natural history with prophylactic agents. Approximately half of the cases were prevented. The current challenge is to achieve...

Cite
Cuzick J. Chemoprevention of breast cancer. Womens Health (Lond). 2006;2(6):853-61doi: 10.2217/17455057.2.6.853.
Cuzick, J. (2006). Chemoprevention of breast cancer. Women's health (London, England), 2(6), 853-61. https://doi.org/10.2217/17455057.2.6.853
Cuzick, Jack. "Chemoprevention of breast cancer." Women's health (London, England) vol. 2,6 (2006): 853-61. doi: https://doi.org/10.2217/17455057.2.6.853
Cuzick J. Chemoprevention of breast cancer. Womens Health (Lond). 2006 Nov;2(6):853-61. doi: 10.2217/17455057.2.6.853. PMID: 19804005.
Copy Download .nbib Format: NLM
Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011.

Ecancermedicalscience

Armitage J, Cuzick J, Elwood P, Longley M, Perkins A, Spencer K, Turner H, Porch S, Lyness S, Kennedy J, Henderson G.
PMID: 22423252
Ecancermedicalscience. 2012;6:245. doi: 10.3332/ecancer.2012.245. Epub 2012 Feb 28.

On November 23rd 2011, the Aspirin Foundation held a meeting at the Royal Society of Medicine in London to review current thinking on the potential role of aspirin in preventing cardiovascular disease and reducing the risk of cancer in...

Cite
Armitage J, Cuzick J, Elwood P, et al. Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011. Ecancermedicalscience. 2012;6:245doi: 10.3332/ecancer.2012.245.
Armitage, J., Cuzick, J., Elwood, P., Longley, M., Perkins, A., Spencer, K., Turner, H., Porch, S., Lyness, S., Kennedy, J., & Henderson, G. (2012). Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011. Ecancermedicalscience, 6245. https://doi.org/10.3332/ecancer.2012.245
Armitage, J, et al. "Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011." Ecancermedicalscience vol. 6 (2012): 245. doi: https://doi.org/10.3332/ecancer.2012.245
Armitage J, Cuzick J, Elwood P, Longley M, Perkins A, Spencer K, Turner H, Porch S, Lyness S, Kennedy J, Henderson G. Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011. Ecancermedicalscience. 2012;6:245. doi: 10.3332/ecancer.2012.245. Epub 2012 Feb 28. PMID: 22423252; PMCID: PMC3298410.
Copy Download .nbib Format: NLM
Comprehensive control of human papillomavirus infections and related diseases.

Vaccine

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S.
PMID: 24332295
Vaccine. 2013 Dec 31;31:H1-31. doi: 10.1016/j.vaccine.2013.10.003.

Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the...

Cite
Bosch FX, Broker TR, Forman D, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:H1-31doi: 10.1016/j.vaccine.2013.10.003.
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A. B., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., Cuzick, J., Castle, P. E., Schiller, J. T., Markowitz, L. E., Fisher, W. A., Canfell, K., Denny, L. A., Franco, E. L., Steben, M., Kane, M. A., Schiffman, M., Meijer, C. J., Sankaranarayanan, R., Castellsagué, X., Kim, J. J., Brotons, M., Alemany, L., Albero, G., Diaz, M., de Sanjosé, S. (2013). Comprehensive control of human papillomavirus infections and related diseases. Vaccine, 31H1-31. https://doi.org/10.1016/j.vaccine.2013.10.003
Bosch, F Xavier, et al. "Comprehensive control of human papillomavirus infections and related diseases." Vaccine vol. 31 (2013): H1-31. doi: https://doi.org/10.1016/j.vaccine.2013.10.003
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 31;31:H1-31. doi: 10.1016/j.vaccine.2013.10.003. PMID: 24332295; PMCID: PMC7605442.
Copy Download .nbib Format: NLM
Assessing opportunities for coordinated R&D in early cancer detection and management in Europe.

International journal of cancer

Ussi AE, Rebolj M, Thorat MA, Bietrix F, Fauvel AC, Hajdúch M, Hill C, Walker I, van Engeland M, Cuzick J, Meijer G.
PMID: 27943265
Int J Cancer. 2017 Apr 01;140(7):1700-1701. doi: 10.1002/ijc.30564. Epub 2016 Dec 27.

No abstract available.

Cite
Ussi AE, Rebolj M, Thorat MA, et al. Assessing opportunities for coordinated R&D in early cancer detection and management in Europe. Int J Cancer. 2016;140(7):1700-1701doi: 10.1002/ijc.30564.
Ussi, A. E., Rebolj, M., Thorat, M. A., Bietrix, F., Fauvel, A. C., Hajdúch, M., Hill, C., Walker, I., van Engeland, M., Cuzick, J., & Meijer, G. (2017). Assessing opportunities for coordinated R&D in early cancer detection and management in Europe. International journal of cancer, 140(7), 1700-1701. https://doi.org/10.1002/ijc.30564
Ussi, Anton E, et al. "Assessing opportunities for coordinated R&D in early cancer detection and management in Europe." International journal of cancer vol. 140,7 (2017): 1700-1701. doi: https://doi.org/10.1002/ijc.30564
Ussi AE, Rebolj M, Thorat MA, Bietrix F, Fauvel AC, Hajdúch M, Hill C, Walker I, van Engeland M, Cuzick J, Meijer G. Assessing opportunities for coordinated R&D in early cancer detection and management in Europe. Int J Cancer. 2017 Apr 01;140(7):1700-1701. doi: 10.1002/ijc.30564. Epub 2016 Dec 27. PMID: 27943265.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 173 entries